{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:44:41Z","timestamp":1784202281220,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Keratoconus (KC) is a progressive corneal ectatic disorder characterized by stromal thinning, irregular astigmatism, and visual impairment. Increasing evidence suggests that oxidative stress plays a significant role in the pathogenesis of KC. Biomarkers such as ischemia-modified albumin (IMA), malondialdehyde (MDA) and total thiol (TT) have been widely used to assess oxidative status. This study aims to evaluate the role of oxidative stress in KC disease by comparing serum levels of IMA, MDA, and TT between KC patients and healthy controls. Material and Methods: Forty patients diagnosed with KC and 43 healthy individuals of similar age and gender were included in the study. Patients with KC were classified in 4 stages according to the modified Krumeich KC classification system. IMA, MDA, and TT levels were compared in serum samples from patient and control groups. Results: Serum IMA levels were 2.52 \u00b1 0.07 in the KC group and 1.2 \u00b1 0.03 in the control group. The difference was statistically significant (p &lt; 0.001). While serum MDA levels were 1.68 \u00b1 0.05 in the KC group, they were 0.74 \u00b1 0.04 in the control group. The difference was statistically significant (p &lt; 0.001). Serum TT levels were 0.82 \u00b1 0.41 in the KC group and 2.23 \u00b1 0.04 in the control group. The difference was statistically significant (p &lt; 0.001). Conclusions: Elevated serum IMA and MDA levels, together with decreased TT levels, in patients with KC are likely associated with increased oxidative stress. These parameters may serve as auxiliary biomarkers for evaluating disease pathophysiology and may represent potential targets for future diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.3390\/medicina62040682","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:14:43Z","timestamp":1775142883000},"page":"682","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Serum Markers of Oxidative Stress and Antioxidant Status in Keratoconus: Ischemia-Modified Albumin, Malondialdehyde, and Total Thiol Levels"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-8313","authenticated-orcid":false,"given":"Serek","family":"Tekin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Yuzuncu Yil University, 65080 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5629-291X","authenticated-orcid":false,"given":"Erbil","family":"Seven","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Yuzuncu Yil University, 65080 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4204-9756","authenticated-orcid":false,"given":"Canan","family":"Demir","sequence":"additional","affiliation":[{"name":"Vocational School of Healthcare, Yuzuncu Yil University, 65080 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halit","family":"Demir","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Faculty of Science, Yuzuncu Yil University, 65080 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Batur","sequence":"additional","affiliation":[{"name":"Urartu Eye Medical Center, 65100 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-270X","authenticated-orcid":false,"given":"Muhammet Derda","family":"\u00d6zer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Faculty of Medicine, Yuzuncu Yil University, 65080 Van, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tekin","family":"Ya\u015far","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Beyoglu Eye and Research Hospital, 34421 Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0039-6257(97)00119-7","article-title":"Keratoconus","volume":"42","author":"Rabinowitz","year":"1998","journal-title":"Surv. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/ICO.0b013e31818cd077","article-title":"Clinical profile and risk factors for keratoplasty and development of hydrops in north Indian patients with keratoconus","volume":"28","author":"Sharma","year":"2009","journal-title":"Cornea"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2016.12.015","article-title":"Age-specific incidence and prevalence of keratoconus: A nationwide registration study","volume":"175","author":"Godefrooij","year":"2017","journal-title":"Am. J. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/jovr.jovr_80_18","article-title":"Corneal oxidative damage in keratoconus cells due to decreased oxidant elimination from modified expression levels of SOD enzymes, PRDX6, SCARA3, CPSF3, and FOXM1","volume":"14","author":"Atilano","year":"2019","journal-title":"J. Ophthalmic. Vis. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/002215540205000306","article-title":"Evidence of oxidative stress in human corneal diseases","volume":"50","author":"Buddi","year":"2002","journal-title":"J. Histochem. Cytochem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8592","DOI":"10.1167\/iovs.11-7732","article-title":"Oxidative stress in keratoconus?","volume":"52","author":"Arnal","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1167\/iovs.04-0549","article-title":"Increased levels of catalase and cathepsin V\/L2 but decreased TIMP-1 in keratoconus corneas: Evidence that oxidative stress plays a role in this disorder","volume":"46","author":"Kenney","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/ICO.0000000000001018","article-title":"Evaluation of serum superoxide dismutase activity, malondialdehyde, and zinc and copper levels in patients with keratoconus","volume":"35","author":"Bayraktar","year":"2016","journal-title":"Cornea"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1432-1327.2001.01846.x","article-title":"Characterization of the Co2+ and Ni2+ binding amino-acid residues of the N-terminus of human albumin: An insight into the mechanism of a new assay for myocardial ischemia","volume":"268","author":"Curtis","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0736-4679(00)00255-9","article-title":"A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia\u2014A preliminary report","volume":"19","author":"Lau","year":"2000","journal-title":"J. Emerg. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ajem.2008.10.038","article-title":"Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome","volume":"28","author":"Kristensen","year":"2010","journal-title":"Am. J. Emerg. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1373\/clinchem.2004.046292","article-title":"Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome","volume":"51","author":"Apple","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mito.2017.05.009","article-title":"Mitochondrial dysfunction and oxidative stress in corneal disease","volume":"36","author":"Vallabh","year":"2017","journal-title":"Mitochondrion"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Halliwell, B., and Gutteridge, J.M. (2015). Free Radicals in Biology and Medicine, Oxford University Press.","DOI":"10.1093\/acprof:oso\/9780198717478.001.0001"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3928\/1081597X-20090401-07","article-title":"Circular keratotomy to reduce astigmatism and improve vision in stage I and II keratoconus","volume":"25","author":"Krumeich","year":"2009","journal-title":"J. Refract. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0009-2797(94)90033-7","article-title":"Biological origin of free radicals, and mechanisms of antioxidant protection","volume":"91","author":"Gutteridge","year":"1994","journal-title":"Chem. Biol. Interac."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1167\/iovs.04-1395","article-title":"Accumulation of mitochondrial DNA damage in keratoconus corneas","volume":"46","author":"Atilano","year":"2005","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/eye.2013.262","article-title":"Increased systemic oxidative stress in patients with keratoconus","volume":"28","author":"Toprak","year":"2014","journal-title":"Eye"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1515\/CCLM.2011.037","article-title":"Ischemia modified albumin changes\u2014Review and clinical implications","volume":"49","author":"Sbarouni","year":"2011","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.clinbiochem.2009.11.018","article-title":"Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus","volume":"43","author":"Kaefer","year":"2010","journal-title":"Clin. Biochem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.20226","article-title":"Evaluation of ischemia-modified albumin in anemia associated to chronic kidney disease","volume":"22","author":"Cichota","year":"2008","journal-title":"J. Clin. Lab. Analy"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.clinbiochem.2010.12.001","article-title":"Ischemia-modified albumin as an oxidative stress biomarker in obesity","volume":"44","author":"Piva","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1373\/clinchem.2004.034371","article-title":"High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis","volume":"50","author":"Borderie","year":"2004","journal-title":"Clin. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/00365513.2017.1422540","article-title":"The significance of thiol\/disulfide homeostasis and ischemia-modified albumin levels to assess the oxidative stress in patients with different stages of diabetes mellitus","volume":"78","author":"Gulpamuk","year":"2018","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_26","first-page":"820853","article-title":"The association between diabetic retinopathy and levels of ischemia-modified albumin, total thiol, total antioxidant capacity, and total oxidative stress in serum and aqueous humor","volume":"2014","author":"Kirboga","year":"2014","journal-title":"J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/IAE.0b013e3181ed8cd1","article-title":"The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde","volume":"31","author":"Turk","year":"2011","journal-title":"Retina"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1080\/02713683.2019.1594925","article-title":"Thiol\u2013Disulfide Homeostasis and Serum Ischemia Modified Albumin Levels in Patients with Primary Open\u2013Angle Glaucoma","volume":"44","author":"Karakurt","year":"2019","journal-title":"Curr. Eye Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Chang, D., Sha, Q., Zhang, X., Liu, P., Rong, S., Han, T., Liu, P., and Pan, H. (2011). The evaluation of the oxidative stress parameters in patients with primary angle-closure glaucoma. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027218"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcrs.2017.10.051","article-title":"Association between cataract progression and ischemia-modified albumin in relation to oxidant\u2013antioxidant profiles in the serum, aqueous humor, and lens","volume":"44","author":"Elmazar","year":"2018","journal-title":"J. Cataract Refract. Sur."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/682\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:42:56Z","timestamp":1775144576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/4\/682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["medicina62040682"],"URL":"https:\/\/doi.org\/10.3390\/medicina62040682","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]}}}